Revolution Medicines, Inc. - Common Stock (RVMD)

CUSIP: 76155X100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
199,316,245
Total 13F shares
112,410,338
Share change
+450,922
Total reported value
$3,111,480,815
Put/Call ratio
53%
Price per share
$27.68
Number of holders
165
Value change
+$13,449,543
Number of buys
101
Number of sells
52

Security key

76155X100

Report period

Q3 2023

Institutions

165

Top holders

10

Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
5.2%
10,289,689
$275,249,182 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
4.7%
9,340,503
$249,858,456 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
4.1%
8,257,616
$220,891,230 30 Jun 2023
13F
EcoR1 Capital, LLC
13F
Company
3.6%
7,198,700
$192,565,225 30 Jun 2023
13F
BVF INC/IL
13F
Company
3.1%
6,255,588
$167,336,979 30 Jun 2023
13F
Third Rock Ventures III, L.P.
3/4/5
10%+ Owner
class O/S missing
5,104,130
$137,811,510 08 Jun 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.5%
5,018,765
$134,253,000 30 Jun 2023
13F
Nextech Invest Ltd.
13F
Company
2.4%
4,839,529
$129,457,401 30 Jun 2023
13F
Bellevue Group AG
13F
Company
2.4%
4,746,000
$126,955,500 30 Jun 2023
13F
STATE STREET CORP
13F
Company
2.4%
4,744,249
$126,908,661 30 Jun 2023
13F
Boxer Capital, LLC
13F
Company
2.4%
4,684,264
$125,304,000 30 Jun 2023
13F
JPMORGAN CHASE & CO
13F
Company
2%
3,967,753
$106,137,393 30 Jun 2023
13F
Woodline Partners LP
13F
Company
1.9%
3,761,375
$100,616,781 30 Jun 2023
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
1.4%
2,783,480
$74,458,090 30 Jun 2023
13F
BAKER BROS. ADVISORS LP
13F
Company
1.4%
2,691,493
$71,997,438 30 Jun 2023
13F
Column Group LLC
13F
Company
1.3%
2,577,220
$68,940,635 30 Jun 2023
13F
Artal Group S.A.
13F
Company
1.2%
2,401,617
$64,243,000 30 Jun 2023
13F
Holocene Advisors, LP
13F
Company
1.1%
2,178,060
$58,263,105 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.98%
1,948,460
$52,121,322 30 Jun 2023
13F
Casdin Capital, LLC
13F
Company
0.91%
1,810,000
$48,417,500 30 Jun 2023
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.88%
1,751,496
$46,852,518 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.84%
1,668,776
$44,637,201 30 Jun 2023
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.66%
1,317,842
$35,233,333 30 Jun 2023
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.61%
1,223,725
$32,734,649 30 Jun 2023
13F
Avidity Partners Management LP
13F
Company
0.54%
1,075,000
$28,756,250 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.49%
983,495
$26,308,492 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.46%
917,693
$24,548,288 30 Jun 2023
13F
Frazier Life Sciences Management, L.P.
13F
Company
0.43%
854,484
$22,857,447 30 Jun 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.36%
711,111
$19,022,219 30 Jun 2023
13F
Rock Springs Capital Management LP
13F
Company
0.35%
702,712
$18,797,546 30 Jun 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.35%
697,679
$18,662,914 30 Jun 2023
13F
FMR LLC
13F
Company
0.29%
582,712
$15,587,547 30 Jun 2023
13F
S.c.a. Candriam
13F
Individual
0.29%
579,948
$15,513,609 30 Jun 2023
13F
Sofinnova Investments, Inc.
13F
Company
0.26%
520,377
$13,920,085 30 Jun 2023
13F
DAFNA Capital Management LLC
13F
Company
0.26%
512,285
$13,703,624 30 Jun 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
0.22%
443,574
$11,865,605 30 Jun 2023
13F
BESSEMER GROUP INC
13F
Company
0.22%
442,442
$11,835,000 30 Jun 2023
13F
Bank of New York Mellon Corp
13F
Company
0.21%
411,541
$11,008,722 30 Jun 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.19%
374,090
$10,006,908 30 Jun 2023
13F
NORGES BANK
13F
Company
0.18%
367,487
$9,830,277 30 Jun 2023
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.18%
360,635
$9,646,986 30 Jun 2023
13F
Integral Health Asset Management, LLC
13F
Company
0.18%
356,000
$9,523,000 30 Jun 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.16%
328,638
$8,791,067 30 Jun 2023
13F
Rafferty Asset Management, LLC
13F
Company
0.16%
324,943
$8,692,225 30 Jun 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.14%
277,390
$7,420,182 30 Jun 2023
13F
MPM BioImpact LLC
13F
Company
0.14%
273,408
$7,313,664 30 Jun 2023
13F
Polar Asset Management Partners Inc.
13F
Company
0.13%
259,700
$6,946,975 30 Jun 2023
13F
Hudson Bay Capital Management LP
13F
Company
0.12%
242,000
$6,473,500 30 Jun 2023
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.11%
218,643
$5,848,700 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
218,481
$5,844,367 30 Jun 2023
13F

Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2023

As of 30 Sep 2023, Revolution Medicines, Inc. - Common Stock (RVMD) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 112,410,338 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., EcoR1 Capital, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Nextech Invest Ltd., Bellevue Group AG, Boxer Capital, LLC, JPMORGAN CHASE & CO, and BVF INC/IL. This page lists 165 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
138
Q3 2023 holders
165
Holder diff
27
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .